Covered recipient · General Payments record
SUBASINI DASH
General Payments · PY2018–2024
$699.49
- Reported across 65 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $272.74 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $82.63 | 5 |
| Lundbeck LLC | $35.95 | 2 |
| UCB, Inc. | $34.60 | 2 |
| Biogen, Inc. | $27.27 | 1 |
| ARGENX US, INC. | $22.50 | 1 |
| Abbott Laboratories | $22.45 | 1 |
| Celgene Corporation | $16.51 | 1 |
| EMD Serono, Inc. | $15.88 | 1 |
| Genentech USA, Inc. | $14.95 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2018202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $22.45 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124958280 | CMS |
| ARGENX US, INC. | $22.50 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142124779 | CMS |
| Biogen, Inc. | $27.27 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104805871 | CMS |
| Celgene Corporation | $16.51 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101175094 | CMS |
| EMD Serono, Inc. | $15.88 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120252086 | CMS |
| Genentech USA, Inc. | $14.95 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133118452 | CMS |
| Lundbeck LLC | $18.70 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145908749 | CMS |
| Lundbeck LLC | $17.25 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145908751 | CMS |
| Teva Pharmaceuticals USA, Inc. | $15.49 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151649514 | CMS |
| Teva Pharmaceuticals USA, Inc. | $16.23 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151649550 | CMS |
| Teva Pharmaceuticals USA, Inc. | $14.64 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151649576 | CMS |
| Teva Pharmaceuticals USA, Inc. | $18.27 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151649594 | CMS |
| Teva Pharmaceuticals USA, Inc. | $18.00 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151649614 | CMS |
| UCB, Inc. | $16.69 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143277803 | CMS |
| UCB, Inc. | $17.91 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143277808 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.